Biogen Pharmachem Industries share news, announcements and annual reports
Share price at the BSE close on 29 Oct 2026. Previous close ₹0.25.
29 Oct: open ₹0.25, high ₹0.25, low ₹0.24
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹26 Cr3,446th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.27
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 22,13,209
Biogen Pharmachem Industries share news and announcements
511 announcements, routine notices left out, newest first. Page 3 of 11.
May 2024
16 May · Board meeting
Meeting on 25 May 2024: audited results
Apr 2024
Feb 2024
1 Feb · Meeting
1 Feb · Meeting
Jan 2024
16 Jan · Board meeting
Meeting on 22 Jan 2024: quarterly results3 Jan · Board meeting
Meeting on 9 Jan 2024
Nov 2023
Oct 2023
26 Oct · Board meeting
Meeting on 1 Nov 2023: quarterly results
Sep 2023
30 Sep · Meeting
30 Sep · Meeting
Aug 2023
3 Aug · Board meeting
Meeting on 10 Aug 2023: quarterly results
Jul 2023
4 Jul · Legal
Jun 2023
30 Jun · Legal
Exchange has sought clarification from Biogen Pharmachem Industries Ltd on June 30, 2023, with reference to Movement in Price. The reply is awaited.
May 2023
8 May · Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
2 May · Board meeting
Meeting on 8 May 2023: audited results
Apr 2023
22 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
10 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Period From April 1, 2022 To March 31, 2023.
Mar 2023
22 Mar · Board meeting
Meeting on 22 Mar 2023
Feb 2023
2 Feb · Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jan 2023
27 Jan · Board meeting
Meeting on 2 Feb 2023: quarterly results
Nov 2022
11 Nov · Submission Of Half Yearly Disclosure On Related Party Transactions.
11 Nov · Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
4 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Sep 2022